NSL-AB-03

N/A

Report date: 2025/04/29 13:47:29
NME

Base Information

Drug NameNSL-AB-03
Drug Alias NameNSL-AB-03
ClassificationSmall molecules
Mechanisms of ActionPrenylated Methylated Protein Methyl Esterase inhibitors
TargetsPrenylated Methylated Protein Methyl Esterase
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFlorida A&M University
China Registration ClassN/A

Develop Information

Active CompaniesFlorida A&M University
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A